Uncategorized
Breaking News: FDA MedWatch – Testosterone and Other Anabolic Androgenic Steroids (AAS): FDA Statement – Risks Associated With Abuse and Dependence
Today the FDA has issued a statement giving approval for “class-wide labeling changes for all prescription testosterone products, adding a new Warning and updating the Abuse and Dependence section toRead More